Source-grounded facts extracted from Sunshine Biopharma Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Sunshine Biopharma Inc. reported the year ended December 31, 2025 results: revenue $36.3 million.
“specific reference in such filing. --- EX-99.1 (PRESS RELEASE) --- EX-99.1 2 sunshine_ex9901.htm PRESS RELEASE Exhibit 99.1 Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year FORT LAUDERDALE, FL / ACCESSWIRE / April 6, 2026 — Sunshine Biopharma Inc. (NASDAQ: SBFM) (“Sunshine Biopharma” or the “Company”), a”
Sunshine Biopharma Inc. engaged M&K CPAS, PLLC as its auditor.
“ublic accounting firm and retained M&K CPAS, PLLC (“M&K”) as its independent auditor. The decision to dismiss Bush & Associates and retain M&K was approved by the unanimous consent of the Company’s board of directors and the Company’s”
Sunshine Biopharma Inc. dismissed Bush & Associates CPA LLC as its auditor.
“Effective September 24, 2025, Sunshine Biopharma Inc. (the “Company”), dismissed Bush & Associates CPA LLC (“Bush & Associates”), as its independent registered public accounting firm and retained M&K CPAS, PLLC (“M&K”) as its independent auditor.”
Michel Roy was appointed as Chief Commercial Officer at Sunshine Biopharma Inc..
“On January 13, 2025, Sunshine Biopharma Inc. (the “Company”) appointed Mr. Michel Roy as the Company’s Chief Commercial Officer.”
Sunshine Biopharma Inc. engaged Bush & Associates CPA LLC as its auditor.
“Sunshine Biopharma, Inc. (the “Company”), retained Bush & Associates CPA LLC (“Bush & Associates”), as its independent registered public accounting firm.”
Sunshine Biopharma Inc. dismissed BF Borgers CPA, PC as its auditor.
“udited by BF Borgers CPA, PC (“Borgers”). On May 3, 2024, the Securities and Exchange Commission (the “SEC”)”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.